Progress in therapeutic antisense applications for neuromuscular disorders.

Progress in therapeutic antisense applications for neuromuscular disorders.

Item
http://www.wikidata.org/entity/Q37609948
Characteristics of Antisense Transcript Promoters and the Regulation of Their ActivityTherapeutics development in myotonic dystrophy type 1.Expression of dog microdystrophin in mouse and dog muscles by gene therapyCirculating Muscle-specific miRNAs in Duchenne Muscular Dystrophy PatientsTherapeutic developments in spinal muscular atrophy.Discovery, synthesis, and biological evaluation of novel SMN protein modulators.Efficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimers.Mechanisms of antisense transcription initiation from the 3' end of the GAL10 coding sequence in vivo.Opportunities and challenges for the development of antisense treatment in neuromuscular disorders.Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis.Making sense of therapeutics using antisense technology.Electrical impedance myography for the in vivo and ex vivo assessment of muscular dystrophy (mdx) mouse muscle.miRNAs as serum biomarkers for Duchenne muscular dystrophy.Therapeutic exon 'switching' for dysferlinopathies?RNA splicing meets genetic testing: detection and interpretation of splicing defects in genetic diseases.Long-term Exon Skipping Studies With 2'-O-Methyl Phosphorothioate Antisense Oligonucleotides in Dystrophic Mouse Models.
P2860

Progress in therapeutic antisense applications for neuromuscular disorders.

Item
http://www.wikidata.org/entity/Q37609948
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Progress in therapeutic antisense applications for neuromuscular disorders.
@en
Progress in therapeutic antisense applications for neuromuscular disorders.
@nl
type
label
Progress in therapeutic antisense applications for neuromuscular disorders.
@en
Progress in therapeutic antisense applications for neuromuscular disorders.
@nl
prefLabel
Progress in therapeutic antisense applications for neuromuscular disorders.
@en
Progress in therapeutic antisense applications for neuromuscular disorders.
@nl
P1433
P1476
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Progress in therapeutic antisense applications for neuromuscular disorders.
@en
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932